Answers are grounded in this paper and cite their sources.
). DOR/ISL exhibited a higher barrier to resistance than DOR/3TC and dolutegravir (DTG)/3TC. Resistance analysis showed no emergence of substitutions at F227, an observation consistent with its ability to confer hypersusceptibility to ISL. Overall, the data demonstrate that DOR/ISL creates a 2-drug combination with a higher barrier to resistance, consistent with the reported clinical activity.
No takes yet. Share an insight, caveat, or question.
Lai et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: